Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix presented at Vascular Discovery 2018

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Resverlogix presented at Vascular Discovery 2018

BearDownAZ

May 17, 2018 03:43PM

Re: Resverlogix presented at Vascular Discovery 2018

growacet

May 17, 2018 04:24PM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix presented at Vascular Discovery 2018

in response to

Resverlogix presented at Vascular Discovery 2018

BearDownAZ

posted on May 17, 2018 04:29PM

The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.

A little dated (2005), but a great (and free) review on FXR by a well respected group at University Medical Center in the Netherlands. It is worth noting that FXR is known to negatively regulate human apo-AI expression in the liver.